Literature DB >> 25619545

Prevalence, awareness, treatment, and control of hypertension in Lebanon.

Dany Matar1, Antonio H Frangieh, Samah Abouassi, Fernand Bteich, Aline Saleh, Elie Salame, Roland Kassab, Rabih R Azar.   

Abstract

The prevalence and factors related to hypertension (HTN) treatment and control are well investigated in the Western world but remain poorly understood in the Middle East and in middle-income countries such as Lebanon. In order to measure the prevalence, awareness, treatment, and control rates of HTN in Lebanon, the authors measured blood pressure (BP) in 1697 adults. The prevalence of optimal BP (<120/80 mm Hg) was 33% and that of pre-HTN (BP ≥120/80 mm Hg but <140/90 mm Hg) was 30%. The prevalence, awareness, treatment, and control (among treated hypertensive) rates of HTN were 36.9%, 53%, 48.9%, and 54.2%, respectively. Overall, only 27% of patients with HTN had their BP under control. Awareness was the most important predictor of treatment. No predictor of control could be identified. The authors concluded that HTN is prevalent in Lebanon and its overall control is low. Improving awareness is the most important target for intervention. ©2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25619545      PMCID: PMC8031573          DOI: 10.1111/jch.12485

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  21 in total

1.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Authors:  Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol: the Pic Indolor Personal Check, Comfort Check, My Check and Travel Check.

Authors:  Giuseppe Germano; Angelos Psimenos; Francesco Sarullo; Alessandro Venditti; Valerio Pecchioli; Roland Asmar
Journal:  Blood Press Suppl       Date:  2009-10

4.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population.

Authors:  R A Tohme; A R Jurjus; A Estephan
Journal:  J Hum Hypertens       Date:  2005-11       Impact factor: 3.012

7.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

8.  Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team.

Authors:  M M Ibrahim; H Rizk; L J Appel; W el Aroussy; S Helmy; Y Sharaf; Z Ashour; H Kandil; E Roccella; P K Whelton
Journal:  Hypertension       Date:  1995-12       Impact factor: 10.190

9.  Prevalence, awareness, treatment, and control of hypertension in Lebanon.

Authors:  Dany Matar; Antonio H Frangieh; Samah Abouassi; Fernand Bteich; Aline Saleh; Elie Salame; Roland Kassab; Rabih R Azar
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-24       Impact factor: 3.738

10.  Terror strikes the heart--September 11, 2001.

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2002 Jan-Feb       Impact factor: 3.738

View more
  29 in total

1.  Knowledge, Attitude, and Practice Toward Hypertension Among Hypertensive Patients Residing in Lebanon.

Authors:  Abdallah Ali; Hassan Bitar; Oukba Briman; Marc Machaalani; Houssam Seifeddine; Mirna N Chahine
Journal:  Vasc Health Risk Manag       Date:  2022-07-13

2.  Observational study of factors associated with morbidity and mortality from COVID-19 in Lebanon, 2020-2021.

Authors:  Moni Nader; Omar Zmerli; Daniel E Platt; Hamdan Hamdan; Salwa Hamdash; Rami Abi Tayeh; Jad Azar; Diana Kadi; Youssef Sultan; Taha Bazarbachi; Gilbert Karayakoupoglou; Pierre Zalloua; Eid Azar
Journal:  PLoS One       Date:  2022-10-19       Impact factor: 3.752

Review 3.  The epidemiology of stroke in the Middle East.

Authors:  Maya El-Hajj; Pascale Salameh; Samar Rachidi; Hassan Hosseini
Journal:  Eur Stroke J       Date:  2016-06-28

4.  Global impact of the new European and American hypertension guidelines: A perspective from Lebanon.

Authors:  Rabih R Azar; Antoine Sarkis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-03-20       Impact factor: 3.738

5.  Prevalence, awareness, treatment, and control of hypertension in Lebanon.

Authors:  Dany Matar; Antonio H Frangieh; Samah Abouassi; Fernand Bteich; Aline Saleh; Elie Salame; Roland Kassab; Rabih R Azar
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-01-24       Impact factor: 3.738

6.  Hypertension prevalence and control among community-dwelling lebanese older adults.

Authors:  Ghina Fakhri; Sarah Assaad; Monique Chaaya
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-09       Impact factor: 3.738

7.  The Health Status of Lebanese Community Pharmacists: Prevalence of Poor Lifestyle Behaviors and Chronic Conditions.

Authors:  Samer Barake; Rayan Tofaha; Deema Rahme; Nathalie Lahoud
Journal:  Saudi Pharm J       Date:  2021-04-22       Impact factor: 4.330

8.  Prevalence and risk factors of hypertension: A nationwide cross-sectional study in Lebanon.

Authors:  Michelle Cherfan; Jacques Blacher; Roland Asmar; Mirna N Chahine; Rouba K Zeidan; Rita Farah; Pascale Salameh
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-31       Impact factor: 3.738

9.  Predictors of Uncontrolled Blood Pressure in Treated Hypertensive Individuals: First Population-Based Study in Lebanon.

Authors:  Rita Farah; Rouba Karen Zeidan; Mirna N Chahine; Roland Asmar; Ramez Chahine; Pascale Salameh; Atul Pathak; Hassan Hosseini
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-01-22       Impact factor: 3.738

10.  May Measurement Month 2019: an analysis of blood pressure screening results from Lebanon.

Authors:  Robert N Najem; Ahmad Halawi; Bassem Tanios; Rasha Ambriss; Rana El Bikai; Giles Partington; Thomas Beaney; Neil R Poulter; Ali K Abu Alfa
Journal:  Eur Heart J Suppl       Date:  2021-05-20       Impact factor: 1.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.